Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies

Details for Australian Patent Application No. 2006319358 (hide)

Owner Abbott GmbH & Co. KG Abbott Laboratories

Inventors Barghorn, Stefan; Keller, Patrick; Labkovsky, Boris; Hillen, Heinz; Striebinger, Andreas; Ebert, Ulrich

Agent Spruson & Ferguson

Pub. Number AU-B-2006319358

PCT Pub. Number WO2007/062852

Priority 60/740,866 30.11.05 US; 60/779,171 03.03.06 US; 60/787,361 30.03.06 US; 60/842,400 05.09.06 US

Filing date 30 November 2006

Wipo publication date 7 June 2007

Acceptance publication date 19 January 2012

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/062852 Priority application(s): WO2007/062852

19 January 2012 Application Accepted

  Published as AU-B-2006319358

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319360-Use of an additive as an agent aiding in the removal of formwork

2006319353-DNA binding site of a transcriptional activator useful in gene expression